APM
GILD icon

Avidity Partners Management’s Gilead Sciences GILD Stock Holding History

Avidity Partners Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.53M Hold
20,000
– – 0.4% 28
2026
Q1 		$2.79M Buy
+20,000
New +$2.8M 0.56% 19
2024
Q3 		– Sell
-255,000
Closed -$17.5M – 88
2024
Q2 		$17.5M Buy
+255,000
New +$17M 0.74% 50
2020
Q2 		– Sell
-200,000
Closed -$15M – 67
2020
Q1 		$15M Buy
+200,000
New +$13.8M 2.07% 18

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Avidity Partners Management's GILD Position: Q2 2026 in Review

Avidity Partners Management held its Gilead Sciences (GILD) position steady in Q2 2026 at 20,000 shares worth $2.53M. The position accounts for 0.4% of the portfolio, ranked #28.

Avidity Partners Management first reported a position in GILD in Q1 2020 and has held it in 4 quarters since. The position peaked at $17.5M in Q2 2024. 2,292 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Avidity Partners Management held 20,000 shares of Gilead Sciences worth $2.53M as of Q2 2026.
  • Avidity Partners Management left its Gilead Sciences share count unchanged in Q2 2026.
  • Gilead Sciences made up 0.4% of Avidity Partners Management's portfolio in Q2 2026, its #28 holding.
  • Avidity Partners Management first reported a position in Gilead Sciences in Q1 2020 and has held it in 4 quarters since.
  • Avidity Partners Management's Gilead Sciences position peaked at $17.5M in Q2 2024.
  • 2,292 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Avidity Partners Management's 13F filing for Q2 2026, filed 14 Aug 2026.